PIK3CA and head and neck squamous cell carcinoma: Furthermore, we assessed only one type of mutations of PIK3CA and we did not check expression on mRNA levels which would be extremely valuable, and we intend to do so because Garcia-Escudero et al. revealed that PIK3CA overexpression, but not mutations, is a poor prognostic marker in HNSCC.